Study of Abemaciclib for Patients with RB-Positive, Triple Negative Metastatic Breast Cancer | VuMedi

Dana-Farber Cancer Institute

Study of Abemaciclib for Patients with RB-Positive, Triple Negative Metastatic Breast Cancer

By Dana-Farber Cancer Institute FEATURING Shom Goel

By Dana-Farber Cancer Institute FEATURING Shom Goel

910 views

April 1, 2019

0 Comments

Login to view comments. Click here to Login